2K06 image
Deposition Date 2008-01-25
Release Date 2009-02-03
Last Version Date 2024-05-01
Entry Detail
PDB ID:
2K06
Keywords:
Title:
Solution structure of the aminoterminal domain of E. coli NusG
Biological Source:
Source Organism:
Escherichia coli (Taxon ID: )
Host Organism:
Method Details:
Experimental Method:
Conformers Calculated:
80
Conformers Submitted:
20
Selection Criteria:
structures with the lowest energy
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Transcription antitermination protein nusG
Gene (Uniprot):nusG
Chain IDs:A
Chain Length:123
Number of Molecules:1
Biological Source:Escherichia coli
Ligand Molecules
Primary Citation
Two structurally independent domains of E. coli NusG create regulatory plasticity via distinct interactions with RNA polymerase and regulators.
J.Mol.Biol. 391 341 358 (2009)
PMID: 19500594 DOI: 10.1016/j.jmb.2009.05.078

Abstact

NusG is a conserved regulatory protein that interacts with elongation complexes (ECs) of RNA polymerase, DNA, and RNA to modulate transcription in multiple and sometimes opposite ways. In Escherichia coli, NusG suppresses pausing and increases elongation rate, enhances termination by E. coli rho and phage HK022 Nun protein, and promotes antitermination by lambdaN and in ribosomal RNA operons. We report NMR studies that suggest that E. coli NusG consists of two largely independent N- and C-terminal structural domains, NTD and CTD, respectively. Based on tests of the functions of the NTD and CTD and variants of NusG in vivo and in vitro, we find that NTD alone is sufficient to suppress pausing and enhance transcript elongation in vitro. However, neither domain alone can enhance rho-dependent termination or support antitermination, indicating that interactions of both domains with ECs are required for these processes. We propose that the two domains of NusG mediate distinct interactions with ECs: the NTD interacts with RNA polymerase and the CTD interacts with rho and other regulators, providing NusG with different combinations of interactions to effect different regulatory outcomes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures